Holen Sie sich die Stockscreener-App
8.61
6.11%
-0.56
Handel nachbörslich:
8.57
-0.04
-0.46%
Schlusskurs vom Vortag:
$9.17
Offen:
$9.15
24-Stunden-Volumen:
10,189
Relative Volume:
0.32
Marktkapitalisierung:
$10.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.80M
KGV:
-7.2353
EPS:
-1.19
Netto-Cashflow:
$-25.19M
1W Leistung:
-14.92%
1M Leistung:
-9.84%
6M Leistung:
+1.49%
1J Leistung:
-12.16%
1-Tages-Spanne:
$8.57
$9.15
1-Wochen-Bereich:
$8.3312
$12.40
52-Wochen-Spanne:
$5.00
$18.35
Sensei Biotherapeutics Inc Stock (SNSE) Company Profile
Firmenname
Sensei Biotherapeutics Inc
Sektor
Branche
Telefon
(240) 243-8000
Adresse
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
Vergleichen Sie SNSE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
8.61 | 11.57M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sensei Biotherapeutics Inc Stock (SNSE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-14 | Eingeleitet | Stephens | Overweight |
| 2021-07-01 | Herabstufung | Berenberg | Buy → Hold |
| 2021-06-29 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-03-01 | Eingeleitet | Berenberg | Buy |
| 2021-03-01 | Eingeleitet | Citigroup | Buy |
| 2021-03-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-01 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Sensei Biotherapeutics Inc Aktie (SNSE) Neueste Nachrichten
Identifying reversal signals in Sensei Biotherapeutics Inc.Market Risk Summary & Safe Entry Trade Signal Reports - newser.com
Measuring Sensei Biotherapeutics Inc.’s beta against major indicesPortfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Published on: 2025-11-03 07:12:45 - newser.com
Is Sensei Biotherapeutics Inc. stock in correction or buying zoneQuarterly Growth Report & AI Forecast Swing Trade Picks - newser.com
How geopolitical tensions affect Sensei Biotherapeutics Inc. stockJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Can Sensei Biotherapeutics Inc. stock deliver consistent earnings growthAnalyst Downgrade & Weekly High Momentum Picks - newser.com
Using data models to predict Sensei Biotherapeutics Inc. stock movementMarket Risk Report & Reliable Trade Execution Plans - newser.com
How Sensei Biotherapeutics Inc. stock reacts to oil prices2025 Key Lessons & Risk Controlled Stock Alerts - newser.com
Sensei Biotherapeutics Halts Lead Drug Development, Explores Sale Or Merger Options - MSN
What technical charts say about Sensei Biotherapeutics Inc. stock2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
Long term hold vs stop loss in Sensei Biotherapeutics Inc.2025 Pullback Review & Fast Entry High Yield Stock Tips - newser.com
Applying big data sentiment scoring on Sensei Biotherapeutics Inc.Weekly Volume Report & Short-Term High Return Strategies - newser.com
How to build a custom watchlist for Sensei Biotherapeutics Inc.Breakout Watch & AI Based Buy/Sell Signal Reports - newser.com
Sensei to ditch its lead candidate and cut workforce amidst strategic review - Yahoo Finance
Sensei Biotherapeutics discontinues cancer drug, explores alternatives By Investing.com - Investing.com Australia
Why hedge funds are buying Sensei Biotherapeutics Inc. stockTrade Volume Summary & Consistent Profit Alerts - newser.com
Custom strategy builders for tracking Sensei Biotherapeutics Inc.Weekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
Is Sensei Biotherapeutics Inc. stock reversal real or fakeMarket Growth Review & Low Risk High Reward Ideas - newser.com
Why Sensei Biotherapeutics Inc. is moving todayWeekly Gains Report & Real-Time Market Sentiment Alerts - newser.com
Published on: 2025-10-31 04:44:02 - newser.com
Leading vs lagging indicators on Sensei Biotherapeutics Inc. performanceWeekly Risk Summary & Capital Efficient Trading Techniques - newser.com
Published on: 2025-10-31 04:26:45 - newser.com
Can momentum traders help lift Sensei Biotherapeutics Inc.Weekly Profit Analysis & Stepwise Entry and Exit Trade Signals - newser.com
Published on: 2025-10-31 04:13:44 - newser.com
Is Sensei Biotherapeutics Inc. (4070) stock protected from inflationJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
Published on: 2025-10-31 02:55:10 - newser.com
Published on: 2025-10-31 00:46:42 - newser.com
Published on: 2025-10-31 00:27:27 - newser.com
Published on: 2025-10-31 00:24:15 - newser.com
SNSE Downgraded to Neutral by HC Wainwright & Co. Analyst Matthe - GuruFocus
Sensei Biotherapeutics stock rating downgraded as company halts key drug By Investing.com - Investing.com Canada
Why Is Retail Going Gaga Over INTS Stocks Today? - Stocktwits
Sensei Biotherapeutics (SNSE) Faces Downgrade as Development Pla - GuruFocus
H.C. Wainwright downgrades Sensei on shelving of solnerstotug - TipRanks
Sensei Biotherapeutics stock rises after announcing strategic review By Investing.com - Investing.com Philippines
Sensei Biotherapeutics stock rises after announcing strategic review - Investing.com
Sensei falls as it scraps cancer drug development, plans to sell itself - TradingView
Sensei will not initiate new clinical study for solnerstotug - TipRanks
Sensei Biotherapeutics Initiates Strategic Review to Maximize Shareholder Value - TradingView
Sensei Biotherapeutics discontinues cancer drug, explores alternatives - Investing.com
Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value - The Manila Times
Finanzdaten der Sensei Biotherapeutics Inc-Aktie (SNSE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):